Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2026-01-22 @ 5:29 AM
Study NCT ID:
NCT02178592
Status:
COMPLETED
Last Update Posted:
2021-01-12
First Post:
2014-06-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Sponsor:
ViiV Healthcare
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
117175
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |